EAACI Congress 2026
12-15 June 2026
Istanbul, Turkey I Booth B01
Join Thermo Fisher Scientific at EAACI 2026 in Istanbul
We are excited to welcome you to EAACI 2026 in Istanbul, where we will showcase the latest advancements in allergy diagnostics and clinical decision-making.
This year, we focus on advancing precision in food allergy diagnosis. We highlight the role of tree nut allergen components, tryptase, and the value of ImmunoCAP™ Specific IgE testing, uniquely combining whole allergens and allergen components to improve diagnostic precision and risk assessment.
Visit our interactive booth, attend our scientific symposium and join expert discussions. Discover how we support healthcare providers at every step- from reliable test results to confident diagnosis and patient management, turning diagnostic insight into meaningful outcomes for patients.
Clarity. Confidence. Test what matters.
Explore how ImmunoCAP Specific IgE tests can help:
- Provide clear answers through accurate risk assessment in food-induced anaphylaxis
- Enable confident diagnosis by differentiating true allergy from cross-reactivity (Pollen Food Allergy Syndrome)
- Support confident clinical decision making by measuring tryptase as a biomarker of mast cell activation in suspected IgE-mediated hypersensitivity reactions
Defining the standard in allergy diagnostics 1-5, ImmunoCAP Specific IgE testing delivers clinically proven, reproducible results that clinicians can trust and act on with confidence, supporting better decisions.
Visit us at Booth B01
What to expect:
- Connect with our experts
Discuss real-life cases and the anaphylaxis patient journey while deepening your understanding of our allergy solutions and their diagnostic impact. - Explore advances in food allergy diagnostics
See how new; tree nut components help provide clearer answers, improve risk stratification, and support confident clinical decisions - Pick up the Algorithms booklet
A practical resource with diagnostic algorithms to support clinical discussions and decision-making
Live Symposium
Tree nut anaphylaxis: patient journey and allergy work up
Join leading experts to explore the anaphylaxis patient journey, focusing on tree nut allergy and how clinically relevant testing supports risk assessment and diagnostic decision-making.
When: Friday, 12 June 2026, 16:30 (TRT, UTC+3)
Where: Room Krakow, Istanbul Congress Centre
Learning Objectives
- Learn about anaphylaxis in patients with tree nut allergy
- Understand the role of tree nut allergen components in identifying high-risk patients
- Explore a stepwise diagnostic approach from clinical history to allergen component and tryptase testing.
- Apply your learnings through latest research and real patient cases
Agenda
| Time | Topic | Speaker |
16:30 |
Welcome and Introduction |
Professor Paul Turner Imperial College London, St Mary's Hospital, London, UK |
16:32 |
Defining anaphylaxis and predicting future risk – focus on tree nut allergies |
Professor Paul Turner Imperial College London, St Mary's Hospital, London, UK |
16:47 |
Enhancing diagnostic precision in tree nut and seed allergies |
Professor Alexandra Santos King´s College London, Evelina Children’s Hospital, Guy’s Hospital, London, UK |
17:02 |
Tree nut allergy after anaphylaxis: Prognosis and management |
Professor Helen Brough King´s College London, Evelina Children’s Hospital, St. Thomas' Hospital, London, UK |
17:17 |
Interactive case-based discussion |
All speakers |
17:27 |
Summary and Closure |
Professor Paul Turner Imperial College London, St Mary's Hospital, London, UK |
Speakers
Prof Paul Turner, Imperial College London, St Mary's Hospital, London, UK
Prof Alexandra Santos, King´s College London, Evelina Children’s Hospital, Guy’s Hospital, London, UK
Professor Helen Brough, King´s College London, Evelina Children’s Hospital, St. Thomas' Hospital, London, UK
Discover the latest scientific advancements in allergy research and diagnostics through poster presentations and expert discussions at EAACI 2026.
Connect with experts and explore insights that support evidence-based diagnostic approaches and clinical decision-making.
Poster session
| Poster title | Author/s | Poster number | Poster presentation (date/time) |
Assessment of automated serum sIgG testing for key bacterial pathogens in Cystic Fibrosis |
M. Tena Campos, R. Pérez Garay (non branded) |
1795 |
Friday 12 June 2026, 12:00–13:00 |
Use and knowledge of Phadiatop Infant and Fx5 in children from a primary care healthcare area |
M. Lázaro Sastre, I. Costa Farinha, N. Otero-Fernández, E. Mazoteras-Martínez, E.-E. Muñoz Díaz, E. Laffond Yges, C. MARTIN GARCIA, S. Arriba-Méndez, A. Núñez Cabrera, I. Dávila |
1446 |
Saturday 13 June 2026, 12:00–13:00 |
Reshaping Allergy Assessment Pathways in the United Kingdom: Modeling System-Level Gains Through Discrete Event Simulation |
M. Tena Campos, C. Suharlim |
128 |
Saturday 13 June 2026, 12:00–13:00 |
Prevalence of sensitisation to alpha-gal glycidal determinant in patients with chronic urticaria, arthropod bites and gastrointestinal symptoms in La Rioja |
I. Vidal Oribe, M. Venturini Díaz, A. Portillo, I. González Mahave, M. D. Del Pozo Gil, J. V. Meneses Sotomayor. |
127 |
Saturday 13 June 2026, 12:00–13:00 |
Resolving heterophile antibody interference in the ISAC multiplex assay using HBT (Scantibodies) |
M. Tena Campos, JM. Martinez Yriarte – non branded |
1809 |
Saturday 13 June 2026, 12:00–13:00 |
Prevalence of sensitization to panallergens and IgG4 profiles against specific foods in patients with allergic-phenotype eosinophilic esophagitis |
J. Domenech Witek, R. González Mendiola, M. Tomás Pérez, AA. Vasquez Bautista, V. Jover Cerdá, C. Carballas Vázquez, MÁ. Echenagusia Abendíbar, D. Gutiérrez Fernández |
100020 |
Sunday 14 June 2026, 12:15-13:15 |
Component ratio analysis supports a targeted diagnostic approach in house dust mite allergy |
M. Tena Campos, JM. Martinez Yriarte - branded |
1316 |
Saturday 13 June 2026, 12:00–13:00 |
Elucidating the Causes of Discordant Results Between Two Specific IgE Assays Using Component-Resolved Diagnostics and Depletion Testing |
M. Nagao, M. Ono, Y. Ichigi, R. Kanai, T. Nishida, N. Yamada, Y. Matsuura, M. Gondo, T. Arima, F. Iwai, Y. Kuwabara, Y. Nishikawa, N. Asakura, T. Fujisawa |
960 |
Sunday 14 June 2026, 12:15-13:15 |
A research tool for development of in-house specific IgE immunoassays - comparison between different methods |
U. Olsson, S. Bohman,Å. Marknell DeWitt |
1646 |
Sunday 14 June 2026, 12:15–13:15 |
Invasion meets allergy: Cortaderia selloana as an emerging grass aeroallergen |
M. Lucas, A. J. Albarracin Contreras, S. Alonso, I. Beares, R. Perez (burgo, Spain), S. Bohman, M. López-Hoyos, F. Rodriguez, A. Gandarillas. |
100579 |
Friday 12 June 2026, 12:00-13:00 |
Long-term analytical stability of ImmunoCAP tryptase supports enduring clinical interpretation thresholds |
C. Mavier, M. Tena, M. Vellby |
1000624 |
Sunday 14 June 2026, 12:15-13:15 |
Poster session
Discover the latest advancements in allergy research and diagnostics at the EAACI 2025 poster session. Engage with leading researchers, explore innovative studies, and discuss findings that are transforming patient care in allergy and clinical immunology.
| Poster Title | Authors | Date & Time | Poster number |
| Evolving the Allergen Encyclopedia - A comprehensive and intuitive educational resource | M. Spangfort, M. Mehic Chaveton, A. Fiocchi, M. Ebisawa, E. Södergren, M. Borres, J. Vitte | 001118 | |
| Development of a specific IgE immunoassay for rAra h 18 | M. Quach, L. Tjäder, L. Mattsson, J. Lidholm, S. Bohman | 000378 | |
| Measurement of eosinophilic and neutrophilic granule proteins and IgE antibodies in nasal mucosal lining fluid in allergic rhinitis – A pilot study | E. Pertsinidou, M. Molin, R. Movérare | 001200 | |
| Performance of a point of care allergy test compared to an established laboratory test for specific IgE in Japanese patients with allergic rhinitis | C. Iwamura, T. Ono, T. Morimoto, T. Hanakita, D. Iwahashi, N. Asakura | 100121 |
| Poster Title | Authors |
| Systemic reactions due to pollen-food-syndrome in a birch prevalent area | M. Westman, A. Asarnoj, N. Andersson, A. Bergström, N. Ballardini, M. P. Borres, I. Kull, E Melén, M. van Hage |
| The effect of early food introduction and frequent skin emollient use on birch sensitization in early childhood | S. Wärnberg Gerdin, H. O. Skjerven, J. Konradsen, M. P. Borres, B. Granum, G. Hedlin, C. Monceyron Jonassen, M. Leblanc, E.M. Rehbinder, K. Rudi, A.C. Staff, C. Söderhäll, M. van Hage, R. Vettukattil, K. C. Lødrup Carlsen, B. Nordlund |
| Infant salivary cortisol levels and risk of allergic sensitization in early childhood | N. Löfvenberg, C-A. Olsson Mägi, S. Wärnberg Gerdin, H. O. Skjerven, M. P. Borres, B. Granum, G. Hedlin, C. Monceyron Jonassen, E.M. Rehbinder, K. Rudi, A.C. Staff, C. Söderhäll, M. van Hage, R. Vettukattil, K. C. Lødrup Carlsen, B. Nordlund |
Immerse yourself in the forefront of allergy research, connect with experts, and gain valuable insights that can enhance your clinical practice. Don’t miss this chance to be part of the scientific dialogue shaping the future of allergy diagnostics.
Why allergy diagnostics matters
Accurate testing plays a critical role in supporting clinical decision-making in allergy diagnosis and management. Complementing patient history and symptoms with specific IgE testing enables a structured approach to identifying clinically relevant sensitizations, assessing risk, and guiding patient management 6. ImmunoCAP™ Specific IgE tests provide reliable, clinically validated results that clinicians can trust in practice.
ImmunoCAP™ allergy solutions
Use the reference standard in in-vitro allergy diagnostics to help optimize your patient management. 7
ImmunoCAP™ allergen component tests
Testing with allergen components helps to uncover a detailed understanding of food, respiratory, environmental, and insect venom allergies.6,8
ImmunoCAP™ Tryptase test
Marker to aid in the diagnosis of anaphylaxis and mastocytosis.9
At Thermo Fisher Scientific, we support healthcare providers with clinically relevant diagnostic solutions that provide clear answers and enable confident decisions from reliable test results to improve patient outcomes.
We look forward to seeing you at EAACI 2026 in Istanbul. Join us to explore how we are advancing anaphylaxis risk assessment and food allergy diagnostics through ImmunoCAP Specific IgE tests.
Confidently diagnose and manage allergies
Access clear interpretation of ImmunoCAP Specific IgE test results and their clinical implications.
Ansotegui IJ, et al. IgE allergy diagnostics and other relevant tests in allergy: a World Allergy Organization position paper. World Allergy Organ J. 2020;13:100080.
Boyce JA, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1-S58.
Hamilton RG. Clinical laboratory assessment of immediate-type hypersensitivity. Arch Pathol Lab Med. 2010;134:975-982.
Wise SK, et al. International consensus statement on allergy and rhinology: allergic rhinitis – 2023. Int Forum Allergy Rhinol. 2023;13:293-859.
Riggioni C, et al. Systematic review and meta-analyses on the accuracy of diagnostic tests for IgE-mediated food allergy. Allergy. 2024;79:324-352.
Dramburg S et al. EAACI Molecular Allergology User's Guide 2.0. Pediatr Allergy Immunol. 2023;34 (Suppl 28):e13854.
Crameri R. Chapter 3a: In Vitro Allergy Diagnosis – Allergen Specific IgE. In: Adkins CA, Agache I, eds. Global Atlas of Allergy. European Academy of Allergy and Clinical Immunology; 2014;166-167.
Canonica, GW, et al., A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013; 6(1):17.
Schwartz, LB, Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006; 26(3):451-63.
